Ultrasound, MRI Aid Placenta Accreta Diagnosis
Placental bulge sign on prenatal ultrasound or MRI helps diagnose severe placental accreta spectrum disorder warranting hysterectomy rather than conservative management
A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)
June 1, 2021 According to an open-access Editor s Choice article in ARRS
American Journal of Roentgenology (AJR), accurate prenatal diagnosis of severe placental accreta spectrum (PAS) disorder by imaging could help guide maternal counseling and selection between hysterectomy and uterine-preserving surgery.
E-Mail
IMAGE: (A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length. view more
Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)
Leesburg, VA, May 27, 2021 According to an open-access Editor s Choice article in ARRS
American Journal of Roentgenology (AJR), accurate prenatal diagnosis of severe placental accreta spectrum (PAS) disorder by imaging could help guide maternal counseling and selection between hysterectomy and uterine-preserving surgery. The findings suggest strong performance of placental bulge in diagnosing severe PAS on both ultrasound and MRI, with potentially relatively stronger performance on MRI, wrote corresponding author Manjiri Dighe from the department of radiology at the University of Washington School of Medicine. Nonetheless, interobserver agreement remain
The 2021 State of the World’s Midwifery (SoWMy) report presents findings on the sexual, reproductive, maternal, newborn and adolescent health (SRMNAH) workforce in 194 countries. The report, produced by UNFPA, the International Confederation of Midwives (ICM), the World Health Organization (WHO) and Novametrics, shows the progress and trends since the 2011 edition, and identifies the barriers and challenges to future advancement.
Take Charge of Your Future Health After a Preeclamptic Pregnancy
Global partners rally around important message on World Preeclampsia Day, May 22, 2021
News provided by
Share this article
Share this article
MELBOURNE, Fla., May 19, 2021 /PRNewswire/ About one in ten women, globally, will experience a hypertensive disorder of pregnancy, including preeclampsia, eclampsia, and HELLP (
Hemolysis,
Low
Platelet count) Syndrome. Each year, these disorders claim the lives of nearly 76,000 mothers and 500,000 babies (as they are a leading cause of preterm birth) worldwide. The health risk does not end with the delivery of her baby. Research studies have shown that preeclampsia survivors are at 2-10 times greater risk for cardiovascular disease (CVD), including stroke, and are four times more likely to have high blood pressure.
4
1PEDEGO Research Unit, Medical Research Center Oulu, Department of Obstetrics and Gynecology, Oulu University Hospital and University of Oulu, Oulu, Finland
2Cancer and Translational Medicine Research Unit, Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland
3Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland
4Department of Oncology, University of Helsinki and Helsinki University Comprehensive Cancer Center, Helsinki, Finland
Preclinical studies have suggested statins have antiproliferative and anti-metastatic effects on endometrial cancer cells. Similarly, most previous epidemiological studies have reported a better prognosis of endometrial cancer in patients who used statins. In this study, we explored the role of statins in the prognosis of endometrial cancer in women with type 2 diabetes in a hospital-based cohort. This retrospective cohort consisted of 119 women with type 2 diabetes who were